首页> 外国专利> Inhibitors of Matrix Metalloproteinases pirimidinonas based merging

Inhibitors of Matrix Metalloproteinases pirimidinonas based merging

机译:基质金属蛋白酶吡虫胺类抑制剂的合并

摘要

Refers to pirimidinonas biciclicas formula I where W together with the carbon Atoms to which they are united in the Group a, B, among others.A - C -, - S -, B -, NR5, and together form a - B - C = C; X is o, S, so, SO2, NR5, and is o, S, R1, R4 and R5 are h, alkyl alquenilo C1 - C2 - C6 C6 alquinilo C2 - C6, among others; R2 and R3 are h,C1 - C6 alkyl, alquenilo C2 - C6, among others; R2 is Halo; n is 0 - 5; R4 and R5 together to complete a Ring EC 3 to 8 members.Preferred compounds are acid 4 - (6 - [3 - (4 - methoxy phenyl) - 1 - inil prop -] - 1 - methyl - 2 - [- 1,4 - dihydro - 2H thieno [2,3-d] pyrimidin-2-yl) - 3 - Methyl benzoic acid,3 - (4 - metanosulfonil - benzyl) - 6 - [3 - (4 - methoxy phenyl) - 2 - 1 - 1 - methyl - inil] - 1H thieno [2,3-d] pyrimidine - 2.4 - dione, among others. It also relates to a Pharmaceutical composition.These compounds are inhibitors of metalloproteinases and are useful for the treatment of Arthritis, osteoarthritis
机译:指式I的拟南芥P. = C; X是o,S,因此,SO 2,NR 5,并且是o,S,R 1,R 4和R 5是h,烷基alquenilo C 1 -C 2 -C 6 C 6 Alquinilo C 2 -C 6等。 R 2和R 3是h,C 1 -C 6烷基,烷烃基C 2 -C 6等。 R2是Halo; n为0-5; R4和R5一起完成3至8个环EC的环。优选的化合物是酸4-(6- [3-(4--甲氧基苯基)-1-吲哚基-]-1-甲基-2-[-1, 4-二氢-2H噻吩并[2,3-d]嘧啶-2-基)-3-甲基苯甲酸,3--(4-亚磺酰基-苄基)-6-[3-(4-甲氧基苯基)-2- 1-1-甲基-甲腈]-1H噻吩并[2,3-d]嘧啶-2.4-二酮等。它还涉及药物组合物。这些化合物是金属蛋白酶的抑制剂,可用于治疗关节炎,骨关节炎

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号